Danaher [DHR] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Danaher Corporation

NYSE
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Danaher Corporation wins in 10 metrics, Idexx Laboratories, Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Danaher Corporation Idexx Laboratories, Inc. Better
P/E Ratio (TTM) 34.61 42.92 Danaher Corporation
Price-to-Book Ratio 2.40 27.85 Danaher Corporation
Debt-to-Equity Ratio 37.17 60.83 Danaher Corporation
PEG Ratio 3.84 2.41 Idexx Laboratories, Inc.
EV/EBITDA 17.69 31.12 Danaher Corporation
Profit Margin (TTM) 14.89% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) 22.94% 29.76% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 22.94% 29.76% Idexx Laboratories, Inc.
Return on Equity 7.08% 66.20% Idexx Laboratories, Inc.
Return on Assets (TTM) 4.19% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $5.26B $1.04B Danaher Corporation
Dividend Yield 0.56% N/A N/A
1-Year Return -10.25% 7.30% Idexx Laboratories, Inc.
Price-to-Sales Ratio (TTM) 5.10 10.38 Danaher Corporation
Enterprise Value $140.38B $46.85B Danaher Corporation
EV/Revenue Ratio 5.67 10.89 Danaher Corporation
Gross Profit Margin (TTM) 60.34% 60.35% Idexx Laboratories, Inc.
Revenue per Share (TTM) $35 $54 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $5.16 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 0.99 1.72 Danaher Corporation
Short % of Float 1.10% 2.74% Danaher Corporation

Danaher Corporation vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

DHR
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%

Performance & Financial Health Analysis: Danaher Corporation vs Idexx Laboratories, Inc.

MetricDHRIDXX
Market Information
Market Cap i$126.39B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i5,174,666480,502
90 Day Avg. Volume i4,357,215516,114
Last Close$181.10$570.00
52 Week Range$160.93 - $242.80$506.91 - $769.98
% from 52W High-25.41%-25.97%
All-Time High$296.06 (Sep 06, 2021)$769.98 (Nov 26, 2025)
% from All-Time High-38.83%-25.97%
Growth Metrics
Quarterly Revenue Growth0.04%0.14%
Quarterly Earnings Growth0.08%0.15%
Financial Health
Profit Margin (TTM) i0.15%0.25%
Operating Margin (TTM) i0.23%0.30%
Return on Equity (TTM) i0.07%0.66%
Debt to Equity (MRQ) i37.1760.83
Cash & Liquidity
Book Value per Share (MRQ)$74.32$20.14
Cash per Share (MRQ)$8.06$2.26
Operating Cash Flow (TTM) i$6.44B$1.18B
Levered Free Cash Flow (TTM) i$4.57B$790.74M
Dividends
Last 12-Month Dividend Yield i0.56%N/A
Last 12-Month Dividend i$1.28N/A

Valuation & Enterprise Metrics Analysis: Danaher Corporation vs Idexx Laboratories, Inc.

MetricDHR (Apr 24, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.6142.92
Forward P/E i19.6434.19
PEG Ratio i3.842.41
Price to Sales (TTM) i5.1010.38
Price to Book (MRQ) i2.4027.85
Market Capitalization
Market Capitalization i$126.39B$44.66B
Enterprise Value i$140.38B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i5.6710.89
Enterprise to EBITDA i17.6931.12
Risk & Other Metrics
Beta i0.991.72
Book Value per Share (MRQ) i$74.32$20.14

Financial Statements Comparison: Danaher Corporation vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDHR (2025)IDXX (2025)
Revenue/Sales i24.57B4.30B
Cost of Goods Sold i10.05B1.64B
COGS % of Revenue i40.9%38.2%
Gross Profit i14.52B2.66B
Gross Margin i59.1%61.8%
Research & Development i1.60B251.21M
Operating Income (EBIT) i4.69B1.36B
Operating Margin i19.1%31.6%
EBITDA i7.17B1.51B
EBITDA Margin i29.2%35.0%
Pre-Tax Income i4.23B1.32B
Pre-Tax Income % of Revenue i17.2%30.8%
Income Tax i633.00M264.73M
Income Tax % of Revenue i2.6%6.2%
Net Income (Profit) i3.61B1.06B
Profit Margin i14.7%24.6%

Balance Sheet & Liquidity Metrics

MetricDHR (2025)IDXX (2025)
Cash & Equivalents i4.62B180.07M
Total Current Assets i12.76B1.41B
Total Current Assets % of Revenue i51.9%32.9%
Total Current Liabilities i6.81B1.15B
Total Current Liabilities % of Revenue i27.7%26.7%
Long-Term Debt i19.50B475.99M
Long-Term Debt % of Revenue i79.4%11.1%
Total Shareholders Equity i52.54B1.61B
Retained Earnings i46.89B6.39B
Retained Earnings % of Revenue i190.9%148.5%
Property, Plant & Equipment i2.14B123.23M

Cash Flow Statement Comparison

MetricDHR (2025)IDXX (2025)
Operating Cash Flow i5.64B1.17B
Operating Cash Flow % of Revenue i23.0%27.3%
Capital Expenditures i-1.12B-124.68M
Free Cash Flow i5.26B1.04B
FCF Margin i21.4%24.2%
Debt Repayment i-500.00M-428.39M
Common Stock Repurchase i-3.09B-1.22B

Short Interest & Institutional Ownership Analysis

MetricDHRIDXX
Shares Short i6.94M1.91M
Short Ratio i1.683.85
Short % of Float i1.10%2.74%
Shares Outstanding i707.70M79.71M
Float Shares i630.65M78.75M
% Held by Insiders i10.78%0.71%
% Held by Institutions i85.08%96.04%
% Held by Public i4.14%3.25%

Dividend Analysis & Yield Comparison: Danaher Corporation vs Idexx Laboratories, Inc.

MetricDHRIDXX
Last 12-Month Dividend i$1.28N/A
Last 12-Month Dividend Yield i0.56%N/A
3-Year Avg Annual Dividend i$10.51N/A
3-Year Avg Dividend Yield i1.11%N/A
3-Year Total Dividends i$31.54N/A
Ex-Dividend DateDec 26, 2025N/A